Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
מצבים רפואיים
Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
CTCA at Western Regional Medical Center, Goodyear, Arizona, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Corona, Corona, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Seacliff, Huntington Beach, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope at Irvine Lennar, Irvine, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Antelope Valley, Lancaster, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope at Long Beach Elm, Long Beach, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope at Newport Beach Fashion Island, Newport Beach, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope South Pasadena, South Pasadena, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope South Bay, Torrance, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Upland, Upland, California, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope Atlanta Cancer Center, Newnan, Georgia, United States
Contact: Principal Investigator (Ravi Salgia)City of Hope at Chicago, Zion, Illinois, United States
Contact: Principal Investigator (Ravi Salgia)
מובילי המחקר
Ravi Salgia, MD
Principal Investigator
City of Hope Medical Center
Jyoti Malhotra [Co-PI], MD
Principal Investigator
City of Hope Medical Center